Universal- Beteiligungs- und Servicegesellschaft mbH
Position in NTLA — Intellia Therapeutics, Inc.
CIK 2057170
FRANKFURT AM MAIN, 2M
Position in NTLA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,394,532
+$1,508,145 QoQ
Shares Held
186,781
+89.4% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 66%
Shared 34%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Universal- Beteiligungs- und Servicegesellschaft mbH holds $693,588,415 across 103 Biotechnology names. NTLA ranks #47 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
338,347 | $151,085,469 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,720 | $84,774,060 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
139,708 | $46,225,185 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
134,724 | $25,469,572 | |
| 5 | INCY |
Incyte Corp
|
235,852 | $22,198,390 | |
| 6 | EXEL |
Exelixis, Inc.
|
489,382 | $20,989,593 | |
| 7 | INSM |
INSMED Inc
|
120,348 | $19,679,304 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
219,652 | $16,493,668 |
All Filings in NTLA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,394,532 | 186,781 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $886,387 | 98,597 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $1,959,074 | 113,438 | Shares | Defined | 2025-10-30 | |
| 2025-06-30 | $609,700 | 65,000 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $462,150 | 65,000 | Shares | Defined | 2025-05-06 | |
| No filing history on record for this holder in this stock. | ||||||